Ostarine + raloxifene
Ostarine + raloxifene has been studied in 4 papers since 2022: none in people yet, 4 in animals; 1 in the past year. The research so far is in animals. The newest paper, Aug 25, 2026: “Improvement of Bone Healing by Combined Treatment with Selective Androgen and Estrogen Receptor Modulators in Female and Male Rats”.
See all 4 papers on ostarine + raloxifene
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Deutsche Forschungsgemeinschaft and 1 more
- Animals4
What did studies of ostarine + raloxifene find?
8Studies of ostarine + raloxifene measured 8 outcomes, among them bone volume fraction, biomechanical properties and luteinizing hormone.
Bone volume fraction
upin rats1
1 study
Bone volume fraction
upin rats1
Ostarine + raloxifene increases bone volume fraction in ovariectomized or orchiectomized rats with osteotomy.
“Increased total, callus, and cortical densities as well as bone volume fraction were observed in the Ost + Ral group”
Animalsin ovariectomized or orchiectomized rats with osteotomy
Calcified tissue international
Biomechanical properties
upin rats1
1 study
Biomechanical properties
upin rats1
Ostarine + raloxifene improves biomechanical properties in ovariectomized or orchiectomized rats with osteotomy.
“Biomechanical properties were improved in the Ral and Ost + Ral groups relative to Ovx/Orx controls.”
Animalsin ovariectomized or orchiectomized rats with osteotomy
Calcified tissue international
Luteinizing hormone
upin rats1
1 study
Luteinizing hormone
upin rats1
Ostarine + raloxifene increases luteinizing hormone in rats (ovariectomized rats).
“Conversely, the combined treatment increased serum phosphorus and luteinizing hormone levels”
Animalsovariectomized ratsserumup to 13 weeksfemales
Calcified tissue international
Serum magnesium
downin rats1
1 study
Serum magnesium
downin rats1
Ostarine + raloxifene decreases serum magnesium in rats (ovariectomized rats).
“Conversely, the combined treatment increased serum phosphorus and luteinizing hormone levels, decreased serum magnesium and calcium”
Animalsovariectomized ratsserumup to 13 weeksfemales
Calcified tissue international
Structural and biomechanical bone parameters
upin rats1
1 study
Structural and biomechanical bone parameters
upin rats1
Ostarine + raloxifene improves structural and biomechanical bone parameters in rats (ovariectomized rats).
“OST + RAL treatment showed a favorable effect on structural and biomechanical bone parameters”
Animalsovariectomized ratsboneup to 13 weeksfemales
Calcified tissue international
Muscle weight
downin rats1
1 study
Muscle weight
downin rats1
Ostarine + raloxifene decreases muscle weight in ovariectomized rats.
“OST + RAL increased muscle nucleus ratio, uterine weight, serum phosphorus, FSH and luteinizing hormone and decreased body and muscle weight, serum calcium.”
Animalsin ovariectomized ratsskeletal musclethirteen weeks
Journal of endocrinological investigation
Prostate androgenic effect
downin rats1
1 study
Prostate androgenic effect
downin rats1
Ostarine + raloxifene decreases prostate androgenic effect in rats (combined treatment in orchiectomized rats).
“OST + RAL-P had an anabolic impact on muscle, reduced androgenic effect on the prostate, and normalized food intake.”
Animalscombined treatment in orchiectomized ratsprostateweeks 0-18
Combination of selective androgen and estrogen receptor modulators in orchiectomized rats
Journal of endocrinological investigation
Muscle anabolism
upin rats1
1 study
Muscle anabolism
upin rats1
Ostarine + raloxifene increases muscle anabolism in rats (combined treatment in orchiectomized rats).
“OST + RAL-P had an anabolic impact on muscle, reduced androgenic effect on the prostate, and normalized food intake.”
Animalscombined treatment in orchiectomized ratsmuscleweeks 0-18
Combination of selective androgen and estrogen receptor modulators in orchiectomized rats
Journal of endocrinological investigation